Dr Anna L. Westermair joins Ethics Talk to discuss her article, coauthored with Dr Manuel Trachsel: “Moral Intuitions About Futility as Prompts for Evaluating Goals in Mental Health Care.”
Dr Jennifer T. McIntosh joins Ethics Talk to discuss her article, coauthored with Dr Mona Shattell: “How Should Suicide Prevention and Healing Be Expressed as Goals of Inpatient Psychiatric Unit Design?”
This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.
Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.
During the 1960s and '70s, the iconography of ads for antipsychotic drugs changed from former depictions of docile white women patients to depictions of hostile black men, reflecting transformations in how American culture viewed race and mental illness.
Emily A. Kuhl, PhD, David J. Kupfer, MD, and Darrel A. Regier, MD, MPH
Revisions to the Diagnostic and Statistical Manual of Mental Disorders aim to ground diagnoses in empirical evidence, make them less stigmatizing, and incorporate assessments of patients' functioning over time.
Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.
Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.